Ποια είναι η τιμή για Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Η τιμή για Reviva Pharmaceuticals Holdings, Inc. (RVPHW) είναι $0.003

Ποια είναι η κεφαλαιοποίηση αγοράς για Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Η κεφαλαιοποίηση αγοράς για Reviva Pharmaceuticals Holdings, Inc. (RVPHW) είναι $343.91K

Reviva Pharmaceuticals Holdings, Inc. (RVPHW) Τιμή και Κεφαλαιοποίηση Αγοράς

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.

Η τιμή για RVPHW	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$47,711.80 $343.91K	NVDA	$5.470T	+1,590,393,280.26%
$38,967.10 $343.91K	AAPL	$4.467T	+1,298,903,163.71%
$36,413.95 $343.91K	GOOG	$4.174T	+1,213,798,343.90%
$32,276.47 $343.91K	MSFT	$3.700T	+1,075,882,122.29%
$24,898.97 $343.91K	AMZN	$2.854T	+829,965,414.19%

Η τιμή για RVPHW

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$47,711.80 $343.91K